Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model

Deutsche Tierarztliche Wochenschrift

Volumn 108, Issue 4, 2001, Pages 168-171

  Abd El Aty, A M ^a   Goudah, A ^b   Abo El Sooud, K ^b  

^a Cairo University   (Egypt)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; DRUG RESIDUE;

ABSORPTION; ANIMAL; ANIMAL DISEASE; ARTICLE; BIOAVAILABILITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; RABBIT; TISSUE DISTRIBUTION;

ABSORPTION; ANIMALS; BIOLOGICAL AVAILABILITY; CEFTAZIDIME; CEPHALOSPORINS; DRUG RESIDUES; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; RABBITS; TISSUE DISTRIBUTION;

EID: 0035321678     PISSN: 03416593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ATEF, M., RAMADAN, A., AFIFI, N., YOUSSEF, S. A. H. (1990): Pharmacokinetic profile of cefotaxime in goats. Res. Vet. Sci., 49, 34-38.
2. BAGGOT, J. D. (1983): Systemic Antimicrobial Therapy in Large Animals, in: BOGAN, J. A.; LEES, P. and YOXALL, A. T. (Eds.): Pharmacological Basis of Large Animal Medicine, Oxford, Blackwell Scientific Publications, pp.45-69.
3. BENNETT, J. V., BRODIE, J. L., BENNER, E. J., KIRBY, W. M. M. (1966): Simplified, accurate method for antibiotic assay of clinical specimens. Applied Microbiol.,14, 170-177.
4. BRUMFITT, W., HAMILTON-MILLER, M. T. (1981): The susceptibility of nosocomial pathogens to ceftazidime. Antimicrob. Agents Chemother., B, 15-21.
5. CRAIG, A. W., SUH, B. (1980): Protein binding and the antibacterial effects: Methods for determination of protein binding in: LORIAN, V. (Ed.): Antibiotics in Laboratory Medicine. Baltimore, Maryland,Williams&Wilkins, pp. 265-297.
6. EL-SAYED, M. G., ATEF, M., EL-KOMY, A. A. (1994): Disposition kinetics of cephradine in normal and Escherichia coli infected goats. Dtsch. Tierärztl. Wschr., 101, 56-60.
7. FOORD, R. D. (1976): Cefuroxime: human pharmacokinetics. Antimicrob. Agents Chemother., 9, 741-747.
8. th Ed, New York, Macmillan Publishing Co, pp.21 and 1083.
9. GUERRINI, V. H., ENGLISH, P. B., FILIPPICH, L. J., SCHNEIDER, J., BOURNE, D. W. A. (1986): Pharmacokinetics of cefotaxime in the sheep and dogs. Vet. Rec.,119, 81-83.
10. HADDAD, N. S., PEDERSOLI, W. M., RAVIS, W. R., FAZELI, M. H., CARSON, R. L. (1985): Combined pharmacokinetics of gentamicin in pony mares after a single IV and IM administration. Am. J. Vet. Res., 46, 2004-2007.
11. HAGEN, K. W. Jr. (1967): Effect of antibiotic-sulphonamides therapy on certain microorganisms in the nasal turbinates of domestic rabbits. Lab. Anim. Care, 17, 77-80.
12. MCELORY, D., RAVIS, W. R., CLARK, C. H. (1986): Pharmacokinetics of cefotaxime in the domestic cat. Am. J. Vet. Res., 4, 86-88.
13. NOMURA, H., MINAMI, J., HITAKA, T., FUGONO, T. (1976): Synthetic β-Lactam antibiotics; structure-activity relationship of α-sulfocephalosporins. J. Antibiot. (Tokyo), 29, 928-936.
14. O'CALLAGHAN, C. H., ACRED, P., HARPER, P. B., RYAN, D. M., KIRBY, S. M., HARDING, S. M. (1980): GR20263, a new broad spectrum cephalosporins with antipseudomanal activity. Antimicrob. Agents Chemother., A, 876-883.
15. nd Ed, Iowa State University Press/Ames, pp.100-104.
16. RATTIE, E. S., RAVIN, L. J. (1975): Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans. Antimicrob. Agents Chemother., 7, 606-613.
17. RULE, R., RUBIO, M., PERELLI, M. C. (1991): Pharmacokinetics of ceftazidime in sheep and its penetration into tissue and peritoneal fluids. Res. Vet. Sci., 51, 233-238.
18. RYAN, D.M., CYNTHIA, H. O., MUGGLETON, P. W. (1976): Cefuroxime, a new cephalosporin antibiotic activity In vivo. Antimicrob. Agents Chemother., 9, 520-525.
19. SHARMA, S. K., SRIVASTAVA, A. K. (1994): Pharmacokinetics and dosage regimen of cefotaxime in cross breed calves following single intramuscular administration. Vet. Res. Comm., 18, 313-318.
20. SILLEY, P., RUDD, A. P., SYMINGTON, W. M., TAIT, A. J. (1988): Pharmacokinetics of cephalexin in dogs and cats after oral, subcutaneous and intramuscular administration. Vet. Rec., 122, 15-17.
21. th Ed, Ames, Iowa, Iowa State University press, pp 39-63.
22. SOBACK, S. (1988): Pharmacokinetics of single doses of cefoxitin given by the intravenous and intramuscular routes to unweaned calves. J. Vet. Pharmacol. Therap., 12, 87-93.
23. SOBACK, S., ZIV, G. (1989): Pharmacokinetics of ceftazidime given alone and in combination with probenecid to unweaned calves. Am. J. Vet. Res., 50, 9, 1566-1569.
24. SOBACK, S., ZIV, G., KOKUE, E. I. (1989): Probenecid effect on cefuroxime pharmacokinetics in calves. . J. Vet. Pharmacol. Therap.,11, 155-162.
25. WEISS, L. G., CARS, O., DANIELSON, B. G., GRAHNEN, A., WIKSTROM, B. (1988): Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemo-filtration. Clin. Nephrology, 30, 282-286.
26. YAMAOKA, K., NAKAGAWA, T., UNO, T. (1978): Statistical moments in pharmacokinetics. J. Pharmacokin. Biopharmaceut., 6, 547-558.
27. ZIV, G., SULMAN, E. G. (1972): Binding of antibiotics to bovine and ovine serum. Antimicrob. Agents Chemother., 2, 206-213.